His primary areas of investigation include Medulloblastoma, Internal medicine, Oncology, Surgery and Pathology. His Medulloblastoma study combines topics from a wide range of disciplines, such as Survival rate, Cancer, Bioinformatics and Genomics. The study incorporates disciplines such as Gastroenterology and Glioma in addition to Internal medicine.
He interconnects Craniospinal radiotherapy, Gerontology, Tp53 mutation, Dacarbazine and Cohort in the investigation of issues within Oncology. The Pathology study combines topics in areas such as Cerebellum, Fusion gene and White matter. His work deals with themes such as Central nervous system disease and Retrospective cohort study, which intersect with Radiation therapy.
His primary areas of study are Internal medicine, Oncology, Surgery, Chemotherapy and Medulloblastoma. Within one scientific family, Eric Bouffet focuses on topics pertaining to Glioma under Internal medicine, and may sometimes address concerns connected to Pathology. His Surgery research focuses on Retrospective cohort study, Survival rate, Regimen, Ependymoma and El Niño.
His research on Chemotherapy frequently links to adjacent areas such as Radiation therapy. Eric Bouffet usually deals with Medulloblastoma and limits it to topics linked to Pediatrics and Disease. His Cancer research study frequently draws connections between adjacent fields such as Cancer.
Eric Bouffet focuses on Internal medicine, Oncology, Radiology, Radiation therapy and Medulloblastoma. He has researched Internal medicine in several fields, including BRAF V600E and Neurofibromatosis. His study in Oncology is interdisciplinary in nature, drawing from both Clinical trial, Trametinib and Low-Grade Glioma.
His study looks at the relationship between Radiation therapy and topics such as Neurocognitive, which overlap with Pediatric brain. His Medulloblastoma research entails a greater understanding of Cancer research. His studies examine the connections between Cohort and genetics, as well as such issues in Brain tumor, with regards to Pediatrics and Cancer.
Eric Bouffet mainly focuses on Internal medicine, Oncology, Clinical trial, Radiology and Cancer. His Internal medicine research incorporates elements of BRAF V600E, Mutation and Neurofibromatosis. His work in the fields of Oncology, such as Progression-free survival and Chemoradiotherapy, intersects with other areas such as Text mining and Molecular composition.
Eric Bouffet has included themes like Medulloblastoma and Clinico pathological in his Radiology study. His Medulloblastoma research integrates issues from Molecular heterogeneity, Disease, Chemotherapy and Cohort. The concepts of his Cancer study are interwoven with issues in Psychological intervention, Cancer research, Disease management and Environmental health.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Medulloblastoma Comprises Four Distinct Molecular Variants
Paul A. Northcott;Andrey Korshunov;Hendrik Witt;Thomas Hielscher.
Journal of Clinical Oncology (2011)
Subgroup-specific structural variation across 1,000 medulloblastoma genomes
Paul A. Northcott;Paul A. Northcott;David J.H. Shih;John Peacock;Livia Garzia.
K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas.
Dong Anh Khuong-Quang;Pawel Buczkowicz;Patricia Rakopoulos;Xiao Yang Liu.
Acta Neuropathologica (2012)
Novel mutations target distinct subgroups of medulloblastoma
Giles Robinson;Matthew Parker;Tanya A. Kranenburg;Charles Lu;Charles Lu.
Intertumoral Heterogeneity within Medulloblastoma Subgroups
Florence M.G. Cavalli;Marc Remke;Marc Remke;Marc Remke;Ladislav Rampasek;John Peacock.
Cancer Cell (2017)
Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency
Eric Bouffet;Valérie Larouche;Brittany B. Campbell;Daniele Merico.
Journal of Clinical Oncology (2016)
Diffuse brainstem glioma in children: critical review of clinical trials
Darren Hargrave;Ute Bartels;Eric Bouffet.
Lancet Oncology (2006)
Epigenomic alterations define lethal CIMP-positive ependymomas of infancy
S. C. Mack;H. Witt;R. M. Piro;L. Gu.
Comprehensive Analysis of Hypermutation in Human Cancer
Brittany B. Campbell;Nicholas Light;David Fabrizio;Matthew Zatzman.
Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations
Pawel Buczkowicz;Christine Hoeman;Patricia Rakopoulos;Sanja Pajovic.
Nature Genetics (2014)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: